TY - JOUR
T1 - Real-time monitoring of cell viability using direct electrical measurement with a patch-clamp microchip
AU - Pathak, Pushparaj
AU - Zhao, Hong
AU - Gong, Zhongcheng
AU - Nie, Fang
AU - Zhang, Tianhua
AU - Cui, Kemi
AU - Wang, Zhiyong
AU - Wong, Stephen T.C.
AU - Que, Long
N1 - Funding Information:
Acknowledgements This work is partly supported by the NSF grant EECS0845370 and NSF-Pfund-2010 to LQ, by NIH U54 CA149196to SW and NIH U54 CA149196 pilot project to HZ.
PY - 2011/10
Y1 - 2011/10
N2 - Real-time tagless monitoring of cell viability using patch-clamp microchips is reported and validated by using fluorescence imaging techniques for the first time. Specifically, four human breast cancer cell lines (MDA-MB231, MDA-MB231-brain metastatic subline (abbreviated as MB231-BR), MB231-BR over-expressing HER2 gene (MB231-BR-HER2), and MB231-BR-vector control for the HER2 (MB231-BR-vector)) have been used for these studies. Systematic experiments on these cells found that the seal impedance/resistance of cells captured by the micro-pipettes always decreases during the process when the cell loses its viability, and therefore it is a valid indicator of live or dead cells. Systematic experiments also found that the Mega-seal of patch-clamp microchip is sufficient for monitoring cell viability. Given its simplicity of direct electrical measurement of cells without fluorescence labeling, this technology may provide an efficient technical platform to monitor the drug effects on cells, thereby significantly benefiting high throughput drug screening and discovery process.
AB - Real-time tagless monitoring of cell viability using patch-clamp microchips is reported and validated by using fluorescence imaging techniques for the first time. Specifically, four human breast cancer cell lines (MDA-MB231, MDA-MB231-brain metastatic subline (abbreviated as MB231-BR), MB231-BR over-expressing HER2 gene (MB231-BR-HER2), and MB231-BR-vector control for the HER2 (MB231-BR-vector)) have been used for these studies. Systematic experiments on these cells found that the seal impedance/resistance of cells captured by the micro-pipettes always decreases during the process when the cell loses its viability, and therefore it is a valid indicator of live or dead cells. Systematic experiments also found that the Mega-seal of patch-clamp microchip is sufficient for monitoring cell viability. Given its simplicity of direct electrical measurement of cells without fluorescence labeling, this technology may provide an efficient technical platform to monitor the drug effects on cells, thereby significantly benefiting high throughput drug screening and discovery process.
KW - Cell viability
KW - Direct electrical measurement
KW - High throughput
KW - Patch clamp microchip
UR - http://www.scopus.com/inward/record.url?scp=80053902402&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=80053902402&partnerID=8YFLogxK
U2 - 10.1007/s10544-011-9564-0
DO - 10.1007/s10544-011-9564-0
M3 - Article
C2 - 21698381
AN - SCOPUS:80053902402
SN - 1387-2176
VL - 13
SP - 949
EP - 953
JO - Biomedical Microdevices
JF - Biomedical Microdevices
IS - 5
ER -